t:slim X2 insulin pump with Control-IQ technology 1.5 for Type 1 Diabetes

"The minimum age for entry into this trial is 6 years and the maximum age is 80, as stated in its inclusion criteria."

"This research project is currently recruiting 200 individuals diagnosed with diabetes mellitus, aged between 6 and 80. In addition to this requirement, participants must demonstrate a total daily insulin dose of at least 2 units per day; have an HbA1c level below 10.5%; be living in the United States full-time, without any planned international travel during the period of study participation; those under 18 years old need to reside with one or more parent/legal guardian who are knowledgeable about emergency procedures for severe hypoglycemia and can contact them in case of an emergency; if over 18 years old they must have someone within 30 minutes that"

"Affirmative. According to the information on clinicaltrials.gov, this study is recruiting participants as of now - it was initially posted August 31st 2022 and edited most recently November 30th 2022. Two hundred individuals need to be enrolled from 14 distinct sites."

"Currently, fourteen sites are onboard for this clinical trial. Examples include Stanford University of Palo Alto, Diabetes & Glandular Disease (DGD) in San Antonio and the University of California at San Francisco. There is an additional eleven locations to boot."

"For this study, the primary measure of success over a three-month period is assessing severe hypoglycemia. Additionally, secondary objectives include gauging postprandial and overall percent time spent at levels lower than 70 mg/dL or 54 mg/dL respectively using continuous glucose monitoring (CGM)."

"That is accurate. Clinicaltrials.gov indicates that the trial, which commenced on August 31st 2022, is actively recruiting participants and seeks to enrol 200 individuals across 14 different sites."